Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

NCT05023486 is registered in ClinicalTrials.gov with Novita Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05023486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05023486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Lead sponsor
Novita Pharmaceuticals, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
December 7, 2021
Completion date
June 30, 2026
Enrollment
121 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic solid tumor malignancies